Laboratory Proficiency Testing Market Worth $1103 Million by 2024 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics (Routine Chemistry), Microbiology (Pathogens, Sterile Tests), Food, Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Water, Technology (PCR,)) - Global Forecast to 2024", published by MarketsandMarkets™, the Laboratory Proficiency Testing Market is projected to reach USD 1,103 million by 2024 from USD 800 million in 2019, at a CAGR of 6.6% during the forecast period.

Browse in-depth TOC on  Laboratory Proficiency Testing Market

249 – Tables

29 – Figures  

310 – Pages  

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949

Proficiency testing forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the growth of the proficiency testing market, globally. Also, the stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth.

The cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by industry, during the forecast period

In the laboratory proficiency testing market, by industry, the cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is primarily driven by the legalization of medical cannabis, growing number of cannabis testing laboratories, rising awareness about the medical use of cannabis, and the increasing availability of analytical testing instruments and software.

Get 10% Free Customization on this Report:-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=144227949

The proficiency testing market for chromatography is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by technology, during the forecast period

In the laboratory proficiency testing market, by technology, the chromatography segment is expected to grow at the highest CAGR during the forecast period. Chromatography is used to carry out complicated separations like amino acid sequencing or pollutant separations, based on differential partitioning between the mobile and stationary phase. The advantages associated with chromatographic testing, such as the increased safety, reliability, and transparency of the pharmaceutical supply chain by testing the identity, strength, purity, quality, and potency of a drug product, and the growth in the pharmaceutical industry as a whole are the major factors driving the growth of this segment.

The Asia Pacific region holds high growth potential in the laboratory proficiency testing market

The Asia Pacific is considered to be the most attractive regional market for laboratory proficiency testing owing to the large base of manufacturers and research laboratories in the region. Also, the growing scientific base and research capabilities in several Asian countries; growth of the Asian pharmaceutical, food, and biologics markets; and the large base of CROs in the region are some of the other major factors driving market growth in the region.

The prominent players operating in the global laboratory proficiency testing market are LGC Limited (UK), Bio-Rad Laboratories (US), Randox Laboratories (UK), Merck (Germany), College of American Pathologists (US), American Proficiency Institute (US), Waters Corporation (US), QACS (Greece), FAPAS (UK), AOAC (US), Phenova Inc. (US), Weqas (Cardiff), Advanced Analytical Solutions, LLC (UK), Bipea (France), Absolute Standards Inc. (US), and NSI Lab Solutions (US).

Label-free Detection Market worth $626 million by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Label-free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chip), Software), Technology (Surface Plasmon Resonance), Application (Binding Kinetics), End User (Pharmaceutical & Biotechnology Companies) & region - Global Forecast to 2025", published by MarketsandMarkets™, the global Label-Free Detection Market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.

Browse in-depth TOC on "Label-free Detection Market"

187 – Tables
29 – Figures  
193 – Pages

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593

The Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.

The instruments segment accounted for the largest share of the product & service segment in the label-free detection market in 2019.

On the basis of product & service, the market is broadly segmented into instruments, consumables and software & services. The consumables segment is further segmented into biosensor chips, microplates and reagents & kits. In 2019, instruments accounted for the largest share of the label-free detection products market owing to the various technological advancements in label-free detection systems.

The surface plasmon resonance segment accounted for the largest share of the technology segment in the market in 2019.

On the basis of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.

The Asia Pacific region is the fastest growing region of the label-free detection market in 2019.

In 2019, Asia Pacific region accounted for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to the rising awareness, increasing government support and funding, and growth in life science research.

Get 10% Customization on this Research Report:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593

Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US)

Browse Related Reports:

Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html

High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

 

Hollow Fiber Filtration Market worth $597 million by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End Users (Pharma, Biotech, CRO, CMO) - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14.5% during the forecast period.

Browse and in-depth TOC on "Hollow Fiber Filtration Market"

194 - Tables
35 - Figures
184 – Pages

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039

The growth of the global Hollow Fiber Filtration Market is driven by factors such as the rising preference for continuous manufacturing, increasing use of single use technologies, and the rising biopharmaceutical industry. In addition, emerging economies, and increased investment cell-based research are expected to provide significant growth opportunities for players in the market.

The PS/PES material segment accounted for the largest share of the Hollow Fiber Filtration Market in 2020.

Based on material, the market is segmented into polymeric and ceramic. The polymeric segment is further sub segmented into PS/PES, Polyvinylidene fluoride (PVDF), and Other polymeric materials. In 2020, PS/PES membrane filters accounted for the largest market share as they are designed to eliminate particulates during standard filtration. They have low protein and drug binding characteristics and are stable at alkaline pH. PS/PES membranes are recommended for aqueous applications and for biological samples. These membranes offer high product recoveries due to characteristics such as low affinity and adsorption. In biopharmaceutical industries, PS/PES membranes are mostly used for ultrafiltration in downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions.

The continuous cell perfusion segment accounted for the largest market share of the Hollow Fiber Filtration Market in 2020.

Based on application type, the market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2020, continuous cell perfusion accounted for the largest market share due to the advantages of hollow fibers in continuous cell perfusion, such as enabling efficient cell separation (with low shear) and allowing robust large-scale manufacturing.

Request Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=267011039

The Asia Pacific region is the fastest-growing region of the Hollow Fiber Filtration Market in 2020.

The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to innovation, a giant talent pool of scientists, low labor, and manufacturing costs. The region has also witnessed mass production because of technology and a rise in continuous manufacturing instead of batch production in the previous era.

Asia Pacific region is also a lucrative market for foreign investors, with key market players having their presence in the region. Over the last decade, CMOs in the Asia Pacific region have impacted the global pharmaceutical manufacturing market. Several small and medium-scale CMOs set up in APAC have obtained US FDA approval for their operations and completed GMP certifications, thus driving the regions market.

Prominent players in the Hollow Fiber Filtration Market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market.

Browse Related Reports:

Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, Nanofiltration), Material (PES, PVDF, PTFE), Application (Final Product (Sterile Filtration), Raw Material, Cell Separation, Water) - Global Forecast to 2025 

https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html

Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html

 

Healthcare Interoperability Solutions Market Worth $4.2 Billion by 2024 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantics), End User and Region - Global Forecast to 2024", published by MarketsandMarkets™, the Healthcare Interoperability Solutions Market is expected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%.

Browse in-depth TOC on "Healthcare Interoperability Solutions Market"

100 – Tables
28 – Figures
174 – Pages  

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

The major factors driving the growth of this market include the growing need to curb increasing healthcare costs and a growing focus on patient-centric care delivery. Moreover, government initiatives for enhancing patient care & safety and government funding for healthcare interoperability are also boosting market growth. 

By type, the services segment is expected to account for the largest share of the Healthcare Interoperability Solutions Market

Based on type, the Healthcare Interoperability Solutions Market is segmented into software and services. The services segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the shifting era towards cloud computing and reduced operational costs for better and faster performance of business processes and applications. This segment includes integration and application management services, support & maintenance services, implementation services, and training and education services.

By software type, the HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period

Based on software type, the Healthcare Interoperability Solutions Market is segmented into EHR interoperability solutions, lab system interoperability solutions, imaging system interoperability solutions, HIE interoperability solutions, enterprise interoperability solutions, and other interoperability solutions. The HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the need for greater access to patient health information and the growing adoption of healthcare IT solutions to enhance patient satisfaction and improve quality care.

North America to dominate the Healthcare Interoperability Solutions Market during the forecast period

North America is expected to account for the largest share of the Healthcare Interoperability Solutions Market in 2019, followed by Europe. The dominance of the North American region can be attributed to the rising demand for quality healthcare delivery, a need to curb increasing healthcare expenditure, and the implementation of favorable initiatives & regulations to improve the overall efficiency of healthcare organizations in the region.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=17705847

The prominent players in the Healthcare Interoperability Solutions Market are Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), iNTERFACEWARE (Canada), Quality Systems, Inc. (US), OSP Labs (US), Epic Systems Corporation (US), ViSolve, Inc. (US), and Jitterbit (US). 

 

Healthcare EDI Market worth $4.4 billion by 2025 - Exclusive Report by MarketsandMarkets™

 According to the new market research report " Healthcare EDI Market by Component (Solution, Service), Delivery Mode (On-premise & Cloud, Mobile) Transaction Type (Claims Management, Payment Remittance, Payments, Healthcare Supply Chain), End-User & Region - Global Forecast to 2025", published by MarketsandMarkets™, the market is projected to reach USD 4.4 billion by 2025 from USD 3.0 billion in 2020, at a CAGR of 7.8% during the forecast period.

Browse in-depth TOC on "Healthcare EDI Market"
129 – Tables
44 – Figures
195 – Pages

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130571438

The growth of this market is majorly attributed to the development of regulations for transaction processes, the rising need to curtail healthcare costs and government support for HCIT implementation. Also, the need for the efficient management of electronic claims and reimbursement transactions (for healthcare providers) is expected to drive demand growth in the healthcare EDI market during the forecast period.

By delivery mode, the mobile EDI segment is expected to grow at the highest growth rate during the forecast period

Among the delivery mode segment, the mobile EDI segment is expected to grow at the highest CAGR during the forecast period. The factors attributing to the high growth of this segment include the technological upgrades in the healthcare industry and growing acceptance of mobile solutions among healthcare providers.

By component, the services segment is expected to record the highest CAGR during the forecast period

The services segment is expected to witness a faster growth rate in this market due to factors such as, the increasing claims volume, increasing complexity, and scale of EDI solutions, as they require extensive training programs. Similarly, a growing trend of outsourcing activities, such as revenue cycle management, claims handling and management, and partner management services is also expected to propel the growth of the services market.

By transaction type, the claims management segment is expected to account for the largest share of the healthcare EDI market

On the basis of the transaction type, the EDI market is segmented into claims management and healthcare supply chain. The claims management segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to the rising adoption of EDI services by healthcare providers and payers and the need to meet regulatory requirements.

By end user, the healthcare payers segment to record the highest CAGR during the forecast period

Based on end user, the healthcare EDI market is segmented into healthcare providers, healthcare payers, medical device & pharmaceutical industries, and pharmacies. The healthcare payers segment is expected to grow at the highest CAGR during the forecast period due to the increasing number of private insurance players in the market.

Get 10% Customization on this Research Report: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=130571438

North America dominates the Healthcare EDI market during the forecast period.

North America is expected to hold the largest market size in the global market during the forecast period, followed by the European region. The rising HCIT expenditure, developed healthcare infrastructure, broad insurance coverage, a favorable regulatory scenario, an increasing number of private healthcare players, growing demand for healthcare supply chain management solutions, and the presence of prominent healthcare IT companies in this region, are responsible for the large share of the North American EDI market.

McKesson Corporation (US), Optum (US), Allscripts Healthcare Solutions Inc. (US), athenahealth (US), and Nextgen Healthcare (US) are the key players operating in the healthcare EDI market. Other prominent players in this market include Cognizant Technology Corporation (US), SSI Group, LLC (US), Cerner Corporation (US), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (US), Dell Technologies Inc. (US), Nextgen Healthcare (US), Synnex Corporation (US), Comarch (Poland), Axway Solutions (US), and Plexis Healthcare Systems (US).

Browse Related Reports:

Revenue Cycle Management/RCM Market by Product & Services (Eligibility Verification, Clinical Coding, CDI, Claims Processing, Denial Management, Outsourcing Services, Cloud), End User(Payers, Hospitals, Outpatient), Covid-19 Impact - Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/revenue-cycle-management-market-153900104.html

Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantics), End User and Region - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html

 

Blood Screening Market worth $3.8 billion by 2026 - Exclusive Report by MarketsandMarkets™

 According to the new market research report "Blood Screening Market by Technology (Nucleic Acid Amplification, (Real-Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4%.

Browse in-depth TOC on "Blood Screening Market"

212 – Tables
44 – Figures
235 – Pages

Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042  

The demand for donated blood is rising because of advancements in healthcare systems and the availability of and the need for sophisticated surgical procedures, such as cardiovascular & transplant surgery, trauma care, and therapy for cancer and blood diseases. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the market.

The reagents & kits segment accounted for the largest share of the blood screening market, by product & service segment, in 2020.

The blood screening market is segmented into reagents & kits, instruments, and software & services. The reagents & kits accounted for the largest share of the market in 2020, mainly due to repeated use of reagents & kits in blood screening procedures due to the rising blood transfusion procedures, and the high consumption.

Nucleic Acid Test segment to register the highest growth rate during the forecast period.

The blood screening market is segmented into nucleic acid test (NAT), enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). In 2020, the nucleic acid test (NAT) segment accounted for the largest share of the market. Factors such as the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies and increasing number of blood donations.

The blood banks segment accounted for the largest share of the blood screening, by end user segment, in 2020.

Based on end users, the blood screening market is segmented into blood banks and hospitals. In 2020, the blood banks segment accounted for the largest share of the market. The growing number of organ transplantation surgeries is driving the growth of this segment, and the increasing demand for donated blood.

Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=267747042  

North America is the largest regional market for blood screening market.

The global market is segmented into five major regions—north America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the market. The North American market growth can be attributed to the increasing healthcare spending, increasing prevalence of chronic disorders, and the highly developed healthcare system in the US and Canada.

The major players operating in this blood screening market are Grifols (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories, Inc. (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), Beckman Coulter, Inc. (Danaher) (US), DiaSorin (Italy), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), Ortho Clinical Diagnostics Inc. (US), GE Healthcare (US), Merck KGaA (Germany), PerkinElmer (US), Bio-Techne Corporation (US), GFE (Germany), Trinity Biotech (Ireland), Mindray (China), Maccura Biotechnology Co., Ltd. (China), Immucor, Inc. (US), Cellabs (Australia), Abnova Corporation (Taiwan), Enzo Biochem, Inc. (US), and Cepheid (US).

Browse Related Report:

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html